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Abstract 
Background: Decision making ability can change with time, depending on mental or physical health. Little is known 
about the factors that determine this change and the relationship of capacity to time. As a pilot for studies using func-
tional mental capacities as an outcome measure, we sought to quantify this relationship measuring change over time 
using competence assessment tools, and rating scales for symptoms and global function.
Methodology: We assessed 37 inpatients in a secure psychiatric hospital. All patients met the diagnostic and statisti-
cal manual of mental disorders-fourth edition and International classification of diseases, 10th edition criteria for an 
Axis 1 mental illness, all with psychosis. Patients were interviewed twice a mean of 323 days apart (median 176 days 
range 17–1221 days). The MacArthur competence assessment tools for consent to treatment (MacCAT-T) and fitness 
to plead (MacCAT-FP) were used to quantify functional capacity along with the Positive and Negative Syndrome Scale 
(PANSS) and global assessment of function (GAF) scale. A comparison was also made between those patients pre-
scribed clozapine in comparison to other antipsychotics.
Results: The number judged by treating psychiatrists to lack capacity either to make a treatment choice or to plead 
in court fell from 35 to 8 %. Change was greatest for those admitted within the previous 9 months. The measures of 
capacity improved between time 1 and time 2 for both consent to treatment and fitness to plead. The measures of 
capacity improved with positive symptoms within the PANSS and with GAF scores. Those with shorter lengths of stay 
at baseline had the greatest improvements in the MacCAT-FP scores. Effect sizes were medium or large (0.3–0.7+). 
As expected, patients prescribed clozapine had larger changes in functional mental capacities and larger effect sizes 
than those prescribed other psychotropics. The results show a strong relationship between the clinicians’ assessment 
of capacity and structured rating scales.
Conclusions: We have shown that there is an improvement in capacity scores with time. More research is needed to 
compare the effect of treatment on capacity at fixed time intervals. It would also be helpful to look at a more general 
patient population.
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Background
It can be shown that modern psychiatric treatments help 
to restore functional mental capacities, even in patients 
with severe mental illnesses such as schizophrenia [1]. 
The extent to which functional mental capacities change 
over time is of great importance when considering the 
legal and human rights protections necessary for men-
tally incapacitated patients, including those detained 
and treated under mental health legislation. The time 
course of impairment and recovery, the extent to which 
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impairments are short term or enduring, and the time 
scale over which changes can be expected, are seldom 
studied.
Rationale
Research in schizophrenia and other severe and endur-
ing mental illnesses should concentrate on functional 
outcomes [2]. Neurocognitive and social cognitive defi-
cits underpin many of the most handicapping functional 
impairments in schizophrenia and schizoaffective dis-
order [3]. Impairment of mental capacity is a particu-
larly serious manifestation of mental disorder, leading to 
impairment of the ability to live independently, to exer-
cise one’s rights and to function in society. A functional 
approach is considered best practice for the assessment 
of mental capacity in legal contexts [4]. The respect for 
an individual’s capacity to refuse or consent to treatment 
is an essential aspect of the individual’s human rights. 
Capacity itself is dynamic and can change with time. It is 
essential that research in this area is conducted to facili-
tate further knowledge and ensure best practice.
Separate functional mental capacities such as abil-
ity to give or withhold consent to treatment and fitness 
to stand trial are not independent of each other [5]. In 
addition the amount of information about treatment can 
directly affect the capacity of a person to make a choice 
[6]. As clinicians we strive to protect patients’ interests 
including the right to self-determination, respect for 
autonomy and the principle of reciprocity by provid-
ing information about treatments in order to restore or 
optimise autonomy [7]. Clinical judgement must be exer-
cised concerning the amount of information disclosed 
but deciding what is material to the individual is dif-
ficult when few items of information can be processed. 
Clarifying the extent and the limits of functional men-
tal capacity would help when deciding the thresholds at 
which the use of assisted decision making, guardianship 
and independent second opinions should be deployed to 
ensure the protection of the human rights of impaired 
persons. Knowledge of the likely time course for changes 
in mental capacity in the course of treatment for severe, 
enduring and disabling mental illnesses is necessary if a 
recovery orientation is to be meaningful.
Based on our experience of using functional mental 
capacity as a meaningful outcome measure for a treat-
ment intervention [1], we sought to examine the param-
eters which might influence susceptibility to change in 
functional mental capacity in future treatment studies. 
We considered factors such as length of stay and the 
interval between measurements. We also sought to assess 
the likely effect size for an intervention that might pro-
duce a change in measures of functional mental capacity, 
such as clozapine for treatment resistant psychosis.
Objectives
In this pilot study, in order to provide an evidence base 
for future studies using functional mental capacities 
as outcome measures, we set out to assess the extent 
to which mental capacities change over time, the basic 
parameters influencing change and the likely effect sizes. 
We hypothesised that factors influencing change in func-
tional mental capacities over time would include time 
since admission and the length of the interval between 
measurements. We also hypothesised that changes in 
symptom severity and global function would be associ-
ated with changes in functional mental capacity meas-
ures. We therefore measured the functional mental 
capacity of patients in a secure forensic hospital at differ-
ent times after admission and change over a wide range 
of time intervals. In this exploratory study we also wished 
to assess the expected effect size for changes in measures 
of functional mental capacity before and after a period of 
observation or treatment as usual.
Methods
Sample and setting
This study sample consisted of 37 patients admitted to 
a secure forensic hospital, the Central Mental Hospital, 
Dundrum, part of the National Forensic Mental Health 
Service for Ireland. We have previously described the role 
of this forensic hospital [8], which is similar to the role of 
forensic hospitals in other jurisdictions. All patients are 
detained under mental health legislation, the majority 
while on remand pending trial or following trial.
During the period of this study, ‘treatment as usual’ 
consisted of a target of 25 h of programmed activities a 
week for each patient as part of an individualized care 
and treatment plan. Care and treatment was organized 
into a system of ‘pillars of care’ including programmes 
for physical health, mental health, substance misuse, 
problem behaviours, self-care and activities of daily liv-
ing, education occupation and creativity, and family and 
social networks [9].
Patients met the ICD-10 criteria (World Health Organ-
isation, 1993) [10] and DSM-IV –TR criteria (American 
Psychiatric Association, 2000) for an Axis 1 mental dis-
order [11].
Research participants were interviewed on two occa-
sions, at baseline “Time 1” and at follow up “Time 2”. All 
patients remained inpatients in the Central Mental Hos-
pital during the study period.
The patient’s length of stay in hospital was recorded 
at each interview. Assessment times were chosen ran-
domly to ensure patients were assessed at varying stages 
of admission, treatment and recovery. Information per-
taining to the patient’s pharmacological treatment was 
recorded.
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The study was approved by the Central Mental Hospital 
research, audit and effectiveness committee. All subjects 
gave informed consent to participate in the study. An 
assessment of functional mental capacity to give consent 
to the research interviews was not required as part of the 
consent process by the research, audit and effectiveness 
committee. The committee considered that Articles 5, 6 
and 17 of the Council of Europe Convention on Human 
Rights and Biomedicine were fully complied with (the 
Orviedo Convention) [12] and Article 6 of the Additional 
Protocol concerning capacity to consent [13].
Reliability
Patients were interviewed by post-membership psychia-
trists, trained in the use of the research instruments. 
Inter-rater reliability was assessed by joint interview-
ing to yield a Cohen’s kappa value for the two McArthur 
instruments of greater than 0.946.
Exclusion criteria
Because this was intended as a study of functional mental 
capacity in patients with severe mental illnesses, exclu-
sion criteria included a primary diagnosis of delirium, 
dementia or learning disability (moderate/severe) or 
other cognitive disorders or inadequate understanding of 
the English language.
Measurement tools
The Macarthur competence assessment tool-consent 
to treatment [14, 15] and the Macarthur competence 
assessment tool-fitness to plead (MacCAT-FP) [16] were 
used. These are well validated structured interview rating 
scales for the measurement of functional mental capaci-
ties. All the participants were inpatients detained by the 
criminal courts and all were subject to mental health leg-
islation. Decisions regarding competence to consent to 
treatment and competence to stand trial were therefore 
relevant to each patient.
The MacCAT–T measures understanding, reasoning 
and appreciation in relation to a proposed treatment, and 
the ability to communicate a choice [14, 15]. It has also 
been validated in England [17]. Each patient is given indi-
vidual information on their disorder, including symptoms 
and diagnosis. They are then informed about the nature, 
benefits and risks of the three treatment options. In this 
study the decision scenario involved an oral antipsy-
chotic, a second oral antipsychotic or no medication. For 
each of the 3 options, 2 positive and 2 negative pieces of 
information were given. There were 12 items of informa-
tion in total. The framing of information regarding risk 
uses both verbal and numerical information [5, 6].
‘Understanding’ examines the patient’s ability to retain 
and retell information in their own words. ‘Reasoning’ 
assesses the ability to foresee the consequences of 
their choices and to make comparisons among various 
options. ‘Appreciation’ rates the ability of the patient to 
personalise to oneself the information given concerning 
health and the potential benefits of treatment. Expressing 
a choice is a simple binary rating.
The Positive and Negative Symptom Scale (PANSS) was 
used as a validated measure of symptom severity [18].
The global assessment of function (GAF) was used as a 
measure of ‘real world’ ability to function [19]. This was 
rated by the researchers who consulted with the primary 
nurse and key worker of each patient.
Criterion and outcome measures
Each patient was clinically assessed by their treating 
psychiatrist to determine functional capacity in two 
domains—capacity to consent to treatment and fitness 
to plead. These ratings were made blind to the research 
assessment of functional capacities. These two assess-
ments were taken as criterion measures because they 
would be accepted in legal settings.
The sample was divided into 2 groups—one group 
received clozapine (n  =  7) treatment and the second 
group (n = 30) received other psychotropic medication.
Statistics
Statistics were calculated using SPSS-20 [20]. The distri-
butions of the group scores were tested for statistically 
significant differences.
Paired T-tests were used to compare changes in mean 
scores from T1 to T2.
The Pearson correlation coefficient (r) was used to 
measure the strength and direction of the relationship 
between pairs of variables. We included all difference 
score variables for MacCAT-T, MacCAT-FP, PANSS and 
GAF.
A one way between group analysis of variance was con-
ducted to explore the effect of a pharmacological treat-
ment on changes in measures of functional capacity 
between Time 1 and Time 2.
Cohen’s d and its 95  % confidence interval was cal-
culated as a measure of effect size in relation to change 
over time and when comparing change between those 
treated with clozapine and others. This was calculated to 
facilitate power calculations for future studies using these 
measures of functional capacity as outcome measures.
Results
Out of 37 patients interviewed, 34 (91.8 %) were male and 
3 (8.2 %) were female. The mean age was 32.3 years (age 
range 19.8–56.4  years) at initial interview (Time 1) and 
33.2 years (age range 19.9–56.8 years) at follow up inter-
view (Time 2). All patients met the ICD-10 criteria and 
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DSM-IV-TR criteria for schizophrenia (n = 31), schizoaf-
fective disorder (n = 2), bipolar affective disorder (n = 2), 
severe depressive episode with psychotic symptoms/ 
major depressive disorder with psychotic features (n = 1) 
and psychotic disorder due to use of psychoactive sub-
stances/ substance induced psychotic disorder (n = 1).
The mean length of stay at Time 1 was 815 days (length 
of stay range 1–6265 days, median 275 days) and at Time 
2 was 1162  days (length of stay range 35–6422  days). 
The mean time interval between Time 1 and Time 2 was 
323  days (Time 1–Time 2 interval range 17–1221  days, 
median 176 days).
When corrected for multiple testing, neither the 
length of stay at T1 nor the interval between T1 and 
T2 correlated with any measure of change in the 
MAC-CAT-T or MAC-CAT-FP scores or sub-scales, 
changes in the PANSS score or sub-scales or the GAF. 
However, when only those with a length of stay at T1 
less than the median were chosen (less than 275 days, 
n = 18), a negative correlation emerged between length 
of stay at T1 and change in the MacCAT-FP between 
T1 and T2 (MacCAT-FP understanding r  =  −0.565, 
p  =  0.015, reasoning r  =  −0.710, p  =  0.001, appre-
ciation r = −0.537, p = 0.022, total score r = −0.647, 
p = 0.004) so that the shorter the length of stay at T1, 
the greater the subsequent increase (improvement) in 
score. No other associations were found with MacCAT-
T, PANSS or GAF.
Criterion measures
At the time of assessment 1 (Time 1) 8 (21.6  %) of the 
subjects were rated unfit to plead by their treating psychi-
atrist and 9 (24.3 %) were rated unable to make a choice 
in relation to treatment; At Time 1, 24 (64.8  %) were 
competent by both criterion tests; 13 (35.1 %) were either 
unfit to plead or did not express a treatment choice or 
both. The two criterion tests of functional mental capac-
ity were not significantly associated at Time 1 (X2 = 3.7, 
df = 1, p = 0.56).
At follow up assessment (Time 2), 2 (5.4 %) of subjects 
were rated by their treating psychiatrist as unfit to plead 
and 2 (5.4 %) were rated not capable of making a choice 
in relation to treatment. At Time 2, 34 (91.9 %) were com-
petent by both criterion tests and 3 (8.1  %) were either 
unfit to plead or did not express a treatment choice. The 
two criterion tests were then associated (X2 = 8.2, df = 1, 
p = 0.004) (Tables 1, 2, 3, 4, 5).
A paired sample T test was conducted to evaluate the 
differences in mean scores on tests of functional capac-
ity, GAF and PANSS at Time 1 and Time 2. Table 2 shows 
that the overall MacCAT-T measure improved between 
Time 1 and Time 2. Measures of understanding, reason-
ing and appreciation all improved with time. All results 
were statistically significant. The MacCAT-FP total and 
individual measures of capacity also improved signifi-
cantly with time with the exception of the appreciation 
scores which improved marginally.
The PANSS total and subscale scores fell (improved) 
between Time 1 and Time 2. Significantly lower PANSS 
positive symptom and general symptom scores were 
observed at Time 2 compared to Time 1 with a marginal 
improvement in PANSS negative symptom scores.
For the GAF, significantly higher (better) mean scores 
were observed at Time 2.
Correlations
The relationship between changes in scores for the vari-
ables (T2  −  T1  =  change) were tested. There was an 
inverse relationship between MacCAT-FP-Total ‘change’ 
and PANSS Positive ‘change’ r  =  −0.358 (p  =  0.030). 
MacCAT-FP-Appreciation ‘change’ and PANSS Posi-
tive ‘change’ r  =  −0.366 (p  =  0.026). This shows an 
association between a decrease in psychopathology and 
an improvement in some measures of capacity over 
time. The correlations between PANSS positive change 
and MacCAT-FP understanding ‘change’ (r  =  −0.285) 
and reasoning ‘change’ (r  =  −0.309) did not reach 
significance.
All changes in PANSS sub-scores correlated inversely 
with changes in GAF scores: PANSS positive ‘difference’ 
and GAF ‘difference’ r  =  −0.547 (p  <  0.001), PANSS 
negative ‘difference’ and GAF difference r  =  −0.424 
(p = 0.009), PANSS general ‘difference’ and GAF ‘differ-
ence’ r  =  −0.550 (p  =  0.000), PANSS-total ‘difference’ 
and GAF ‘difference’ r = −0.633 (p < 0.001). This shows 
that with a reduction in psychopathology there is an 
improvement in the global level of functioning between 
Time 1 and Time 2.
A one way between group analysis of variance was 
conducted to explore the association between the treat-
ing clinician’s assessment of fitness to plead and changes 
in measures of functional capacity between Time 1 and 
Table 1 Fitness to plead and ability to make a choice rated 
as per treating Psychiatrist at time 1 and 2
Time 1, n (%) Time 2, n (%)
Fitness to plead
 Fit to plead 29 (78.3) 35 (94.6)
 Unfit to plead 8 (21.6) 2 (5.4)
Ability to express a treatment choice
 Expresses a treatment choice 28 (75.7) 35 (94.6)
 Cannot express a treatment choice 9 (24.3) 2 (5.4)
Either unfit or unable to express a treatment choice
 Capable (both) 24 (64.8) 34 (91.9)
 Either incapacity 13 (35.1) 3 (8.1)
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Time 2. The sample was divided into 2 groups—one 
group for whom the clinicians’ assessment of fitness to 
plead changed (all from unfit to fit n = 6) between Time 
1 and Time 2 and the second group (n = 31) for whom 
the clinicians’ assessment of their fitness to plead did not 
change between Time 1 and Time 2. There was a signifi-
cant difference at the p < 0.05 level in the mean change 
in MacCAT-T- understanding and MacCAT-FP under-
standing, reasoning, appreciation and total scores for the 
2 groups.
Table 2 Paired t test evaluating differences in mean scores of functional capacity, GAF and PANSS at time 1 and 2
Time 1 Time 2 Time 2-Time 1 Effect size ANOVA
Mean SD Mean SD Mean difference 95 % CI Cohen’s d 95 % confidence 
interval
T p
N = 37 N = 37 N = 37 Lower Upper Lower Upper df = 36 2-tailed
MacCAT-T
 Understanding 4.1 1.8 5.1 1.4 0.9 0.4 1.5 0.62 0.15 1.09 3.6 0.001
 Reasoning 3.0 2.6 4.7 2.8 1.6 0.5 2.7 0.63 0.16 1.09 3.0 0.004
 Appreciation 1.7 1.6 2.3 1.5 0.7 0.2 1.1 0.39 −0.07 0.85 3.2 0.003
 Total 8.9 5.1 12.1 5.0 3.2 1.6 4.8 0.63 0.17 1.10 4.1 <0.001
MacCAT-FP
 Understanding 10.9 5.0 12.5 4.4 1.6 2.2 3.0 0.34 −0.12 0.79 2.3 0.025
 Reasoning 6.5 3.8 7.7 3.4 1.2 0.1 2.4 0.33 −0.13 0.79 2.2 0.038
 Appreciation 7.3 4.5 8.6 3.8 1.2 0.1 2.6 0.31 −0.14 0.77 1.8 0.075
 Total 24.8 12.5 28.8 10.4 4.1 0.5 7.6 0.54 0.07 1.00 2.3 0.025
GAF 49.8 16.5 59.7 16.0 9.8 4.2 15.5 0.61 0.14 1.08 3.6 0.001
PANSS
 PANSS positive 15.7 8.1 12.2 5.7 −3.6 −5.7 −1.5 0.49 0.04 0.96 −3.5 0.001
 PANSS negative 20.1 6.9 17.4 7.9 −2.7 −5.5 0.1 0.38 −0.07 0.84 −1.9 0.058
 PANSS general 34.5 7.9 27.4 8.0 −7.1 −9.7 −4.4 0.89 0.42 1.37 −5.4 <0.001
 PANSS total 70.4 17.3 56.6 19.5 −13.8 −19.8 −7.7 0.75 0.28 1.22 −4.7 <0.001
Table 3 For those who changed from  unfit to  plead to  fit as  judged by  their treating psychiatrist, one way ANOVA 
of change in measures of functional capacity between Time 1 and Time 2
Note that six who had been unfit became fit by T2








Mean SD mean SD Cohen’s d 95 % confidence  
interval
F P
N = 31 N = 6 Lower Upper
MacCAT-T difference T2 − T1
 Understanding difference 0.61 1.3 2.7 1.7 1.38 0.45 2.31 10.8 0.002
 Reasoning difference 1.62 3.1 1.5 4.0 0.03 −0.84 0.91 0.0 0.930
 Appreciation difference 0.64 1.3 0.75 1.4 0.08 −0.79 0.96 0.0 0.857
 Total difference 2.9 4.4 4.9 6.4 0.36 −0.51 1.24 0.9 0.344
MacCAT-FP difference T2 − T1
 Understanding difference 0.83 3.6 5.7 4.9 1.13 0.22 2.04 7.9 0.008
 Reasoning difference 0.58 3.1 4.5 3.4 1.20 0.29 2.12 7.9 0.008
 Appreciation difference 0.42 3.5 5.50 5.0 1.17 0.26 2.09 9.4 0.004
 Total difference 1.80 8.8 15.7 12.1 1.31 0.39 2.24 11.1 0.002
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Change in capacity to make a treatment choice
A one way between group analysis of variance was con-
ducted to compare those for whom the treating psychia-
trist found had regained the ability to make a treatment 
choice (n = 7, all became competent) with those who had 
no change in ability to make a treatment choice (n = 30). 
Changes in measures of functional capacity between T1 
and T2 were compared. There was a significant difference 
at the p < 0.05 level in the mean change in MacCAT-T- 
understanding and in MacCAT-FP understanding, rea-
soning, appreciation and total scores for the 2 groups.
Clozapine
There was a significant difference at the p < 0.05 level in 
the mean change in MacCAT-T- Total and MacCAT-T 
appreciation scores for the 2 groups.
Discussion
Key results
We have shown that measures of functional capacity can 
change over time while receiving ‘treatment as usual’ 
in a secure forensic hospital. We found improvements 
between Time 1 and Time 2 for both capacity to consent 
to treatment and fitness to plead.
Improvement in measures of functional capac-
ity occurred for total scores and sub-scale scores. This 
was also evident in the clinical assessment of capac-
ity. Improvements in functional mental capacity were 
accompanied by improvements in symptom severity and 
in global function. The magnitude of change was greatest 
when assessment commenced within the first 9 months 
(275  days) after admission though this was statistically 
significant only for the MacCAT-FP. The length of the 
Table 4 For those who changed from unable to express a treatment choice to able, one way ANOVA of change in scores 
on McCAT-T and MacCAT-FP (T2 − T1)
Note that 7 who had been unable to express a choice became capable
Means (standard deviation) No change in  
ability to express a 
treatment choice
Change in  
ability to express a 
treatment choice
Effect size ANOVA
Mean SD Mean SD Cohen’s d 95 % confidence  
interval
F P
N = 30 N = 7 Lower Upper
MacCAT-T difference T2 − T1
 Understanding difference 0.6 1.4 2.4 1.7 1.16 0.29 2.02 7.7 0.009
 Reasoning difference 1.3 3.4 2.7 2.2 0.49 −0.34 1.32 1.0 0.32
 Appreciation difference 0.5 1.3 1.1 1.2 0.48 −0.36 1.29 1.2 0.27
 Total difference 2.5 4.8 6.2 3.6 0.87 0.03 1.72 3.5 0.68
MacCAT- FP difference T2 − T1
 Understanding difference 0.87 3.7 4.9 4.9 0.93 0.08 1.78 5.8 0.022
 Reasoning difference 0.6 3.0 3.8 3.9 0.92 0.07 1.77 5.8 0.021
 Appreciation difference 0.27 3.1 5.4 5.3 1.18 0.32 2.05 11.5 0.002
 Total difference 1.7 8.7 14.1 12.4 1.16 0.29 2.02 9.8 0.003
Table 5 Change in scores for MacCAT-T between T1 and T2 comparing those treated with clozapine (n = 7) and all others 
(n = 30)
Mean (standard deviation) Other psychotropics Clozapine Effect size ANOVA
Cohen’s d 95 % confidence  
interval
F P
N = 30 N = 7 Lower Upper
MacCAT-T difference T2 − T1
 Understanding difference 0.7 (1.4) 2.0 (2.0) 0.75 −0.09 1.59 4.1 0.051
 Reasoning difference 1.2 (3.1) 3.4 (3.1) 0.71 −0.13 1.55 2.9 0.097
 Appreciation difference 0.3 (1.0) 2.3 (0.9) 2.10 1.15 3.05 22.0 0.001
 Total difference 2.2 (4.2) 7.7 (4.8) 1.22 0.35 2.09 9.3 0.004
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interval between assessments did not appear to relate to 
the magnitude of change. Clozapine treatment appeared 
to be associated with greater improvements in functional 
capacity scores. Effect sizes generally were moderate 
(greater than 0.3) or large (greater than 0.7).
Limitations
This study has many drawbacks. The patients are highly 
selected forensic patients and so these results may not 
generalise to other patient groups. Patients with schizo-
phrenia and schizoaffective disorder accounted for 89 % 
of the sample with the remainder made up of affective 
psychoses. The interval between T1 and T2 had a very 
wide range, although this was also an advantage when 
exploring an unquantified phenomenon. It is possible 
that for some patients, measures of functional mental 
capacity might have varied more than once (improved, 
deteriorated, improved again) during the longer observa-
tion periods.
The numbers assessed are relatively few. A larger sam-
ple would have permitted further analysis of interactions 
between factors influencing change in mental capacities. 
Complex inter-relationships are likely between symptom 
severity, global function and functional mental capaci-
ties. A much larger sample would be required in order to 
study such effects.
The clinical assessment of capacity to make a treatment 
choice and fitness to plead agreed much more closely 
at the end of the study than at the beginning. This may 
indicate a true difference between thresholds for these 
criteria, or greater consistency about competence (more 
common at the end of the study) than about incompe-
tence (more common at the beginning of the study), as 
appears to have been the case.
Interpretation
The clinical factors relevant to change in functional 
capacity can only be described tentatively based on 
this study. It appears that largest effect sizes for change 
in functional mental capacities occur when measure-
ment commences during the first year after admission. 
Measurements of functional mental capacity and global 
function improved at the same time as improvement in 
PANSS positive symptoms such as active delusions, hal-
lucinatory behaviour and excitement. There were no 
statistically significant relationships between changes in 
measures of functional mental capacity and changes in 
negative symptoms such as disturbance of volition, active 
social avoidance and poor attention. The measurement of 
global function was also associated with improvement in 
all measures of mental capacity. Other researchers have 
shown complex relationships between insight (aware-
ness of illness), symptoms and executive function, with 
different measures improving at different time intervals 
in the year after first presentation with schizophrenia 
spectrum disorders [21]. Psychiatric and general hospital 
patients may differ according to whether impairments of 
understanding, reasoning or appreciation are the key ele-
ments impairing decision making capacity [22].
Studies of change in mental capacity over time, and 
studies relating this to treatment, remain rare [1]. The 
MacArthur competence assessment tool-fitness to plead 
(MacCAT-FP) has been shown to be sensitive to change, 
with improvements in capacity during hospital treat-
ment [16]. In one recent 18  month longitudinal study 
concerning patients with schizophrenia, 20  % improved 
and 24 % had worsening capacity to give or withhold con-
sent to research, with 4 % falling below a pre-determined 
threshold over the course of the study [23]. A longitudi-
nal study of patients with dementia over 9 months using 
the MacCAT-T also demonstrated the expected decline 
in decision making capacity, particularly reasoning, and 
in neuropsychological function including logical mem-
ory [24]. A further study using the MacArthur Consent 
to Research instrument showed modest time dependent 
improvements in understanding and reasoning with no 
change in appreciation scores and general stability. There 
was more variation in scores for patients with schizo-
phrenia compared to bi-polar disorder [25].
The treating psychiatrist is responsible for the pre-
scription of psychotropic medication in alleviating the 
symptoms of psychotic symptoms. In this study several 
antipsychotics were prescribed. A comparison was made 
between those patients who were prescribed clozapine 
and those who were prescribed other antipsychotic med-
ications. Results show that those who were prescribed 
clozapine had greater improvements in some measure-
ments of capacity than those prescribed other psycho-
tropic medications.
Treatment included much more than medication. All 
patients had an individual care plan addressing physi-
cal health, mental health, substance misuse problems, 
problem behaviours, activities of daily living, education 
and occupation, family and other relationships [9, 26]. 
A minimum quality standard aims for 25 h per week of 
meaningful activity composed within these ‘pillars’ of 
care. This represents ‘treatment as usual’ in this forensic 
hospital at this time. When treatments are individualised 
and complex, time since admission and time between 
assessments may emerge as the only correlates of treat-
ment that can be aggregated and analysed. However we 
have published the results of specific assessment instru-
ments for progress in these domains as related to leave, 
moves between levels of therapeutic security and condi-
tional discharge [27–29]. We have also published results 
of assessments of neurocognitive and social cognitive 
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impairments in patients with schizophrenia and schizoaf-
fective disorder in a forensic secure hospital [3]. Future 
research in this group of patients will study the relation-
ship between measures of neurocognitive and social cog-
nitive function, treatment participation, engagement and 
changes in functional mental capacity.
Other factors that might have influenced the improve-
ment in capacity scores over time while in a secure foren-
sic hospital might include abstinence from alcohol and 
illicit substances and a benzodiazepine free environment. 
Hospital care also provides a safe, structured environ-
ment with daily activities. This may diminish the stress 
and arousal associated with mental illness and the asso-
ciated socioeconomic deprivation, relationship problems, 
high expressed emotion and chaotic lifestyle.
Generalisability
Although we have demonstrated an improvement in 
capacity scores over time, we cannot definitively say 
what this improvement is attributed to. Further research 
assessing mental capacities and other variables as soon 
as possible after admission and at fixed intervals sub-
sequently, up to a year or more would be required to 
establish time courses and causal relationships between 
treatments, symptoms, global function and functional 
mental capacities. Research is also needed in a non-
forensic population of psychiatric patients.
In this sample of patients with severe, enduring and 
disabling mental disorders, these results indicate that 
treatment given to alleviate symptoms and restore a per-
son’s capacity is broadly effective. This is in line with the 
ethical principle of reciprocity—if a person’s autonomy is 
limited by law and their decisions are made by substitu-
tion, then treatment should offer at least the possibility 
of restoring decision making capacities [4]. In addition, 
there is always an assumption of capacity. Capacity to 
consent to research is a functional capacity. Like all func-
tional capacities it is specific to that function. A person 
may lack capacity to consent to treatment but retain 
another functional capacity e.g. to enter a plea in court, 
or to make a will. Therefore evidence that a person or 
members of a study sample lack functional capacity to 
consent to treatment is not evidence that they lack capac-
ity to consent to research. In the present study, we found 
that the two criterion measures of functional capacity – 
to consent to treatment and to plead in court—were not 
correlated at baseline. It follows that there is no evidence 
for an assumption of impaired capacity to consent to 
research at baseline.
Conclusions
The aim of the study was to assess the relationship 
between functional mental capacities and time. It has 
been demonstrated that there is an improvement in 
capacity scores with time. This is greatest in the first 
year after admission. The results of this study show good 
agreement between the clinician’s assessment of capac-
ity and the structured rating scales. This reinforces the 
importance of combining clinical judgement with semi 
structured tools for assessment of capacity [14–16, 30]. 
The Macarthur competence assessment tools are suitable 
instruments for assisting the clinician in detecting defi-
cits in decision making abilities. These instruments pro-
vide a structured way of assessing capacity, or of assisting 
the clinician in assessing capacity, both when considering 
that capacity might be impaired and when considering 
whether capacity has been restored.
They should always be used as part of a thorough clini-
cal evaluation to ensure that other factors that might 
limit decision making autonomy are also assessed.
Translating the research validation of structured pro-
fessional judgement instruments such as these into rou-
tine practice would be facilitated by clinical training 
standards and by legislative structures protecting the 
rights of the mentally impaired or incapacitated. The 
use of such instruments may be worth considering when 
setting standards for expert evidence and when train-
ing judges or tribunals in assessing the quality of expert 
evidence.
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